An in-depth look to LUMOSA THERAPEUTICS CO LTD operating, investing, and financing activities

6535 free cash flow for Q3 24 is -51.78 M TWD. For 2023, 6535 free cash flow was -334.53 M TWD and operating cash flow was -320.21 M TWD.